In the US, Capreomycin (capreomycin systemic) is a member of the drug class streptomyces derivatives and is used to treat Tuberculosis, Active.
US matches:
- Capreomycin
- Capreomycin Injection
- Capreomycin Sulfate
UK matches:
- Capreomycin Injection (SPC)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J04AB30
CAS registry number (Chemical Abstracts Service)
0011003-38-6
Chemical Formula
C25-H44-N14-O8
Molecular Weight
668
Therapeutic Category
Antibacterial: Polypeptide
Chemical Name
Antibiotic produced by Streptomyces capreolus
Foreign Names
- Capreomycinum (Latin)
- Capreomycin (German)
- Capréomycine (French)
- Capreomicina (Spanish)
Generic Names
- Capreomycin (OS: BAN)
- Capréomycine (OS: DCF)
- CAM (IS)
- Capromycin (IS)
- L 29275 (IS)
- Capreomycin Sulfate (OS: USAN)
- Capreomycin Sulphate (OS: BANM)
- Capreomycin Sulfate (PH: USP 32)
- Capreomycin Sulphate (PH: BP 2002)
Brand Names
- Capastat
Akorn, United States; Aspen, Australia; Dista, Spain; IFET, Greece; King Pharmaceuticals, United Kingdom; Lilly, Peru; Lilly, Russian Federation - Lykocin
Dr. Reddy's, Russian Federation
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
SPC | Summary of Product Characteristics (UK) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment